142 related articles for article (PubMed ID: 24719123)
1. Comparison of full lesion coverage versus spot drug-eluting stent implantation for coronary artery stenoses.
Kim S; Yun KH; Kang WC; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Yonsei Med J; 2014 May; 55(3):584-91. PubMed ID: 24719123
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long versus short ("spot") drug-eluting stenting for long coronary stenoses.
Katritsis DG; Korovesis S; Tzanalaridou E; Giazitzoglou E; Voridis E; Meier B
Am J Cardiol; 2009 Sep; 104(6):786-90. PubMed ID: 19733712
[TBL] [Abstract][Full Text] [Related]
3. [Long-term outcomes of intravascular ultrasound-guided drug-eluting stent implantation in patients with chronic kidney disease: ULTIMATE CKD subgroup analysis].
Gao XF; Lu S; Han L; Qian XS; Ge Z; Kong XQ; Kan J; Zhang JJ; Chen SL
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):136-142. PubMed ID: 33611899
[No Abstract] [Full Text] [Related]
4. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.
Li SJ; Ge Z; Kan J; Zhang JJ; Ye F; Kwan TW; Santoso T; Yang S; Sheiban I; Qian XS; Tian NL; Rab TS; Tao L; Chen SL
JACC Cardiovasc Interv; 2017 May; 10(10):986-995. PubMed ID: 28456699
[TBL] [Abstract][Full Text] [Related]
5. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
7. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
9. Impact of the stent length on long-term clinical outcomes following newer-generation drug-eluting stent implantation.
Choi IJ; Koh YS; Lim S; Kim JJ; Chang M; Kang M; Hwang BH; Kim CJ; Kim TH; Seo SM; Shin DI; Park MW; Choi YS; Park HJ; Her SH; Kim DB; Kim PJ; Lee JM; Park CS; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Seung KB
Am J Cardiol; 2014 Feb; 113(3):457-64. PubMed ID: 24332246
[TBL] [Abstract][Full Text] [Related]
10. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
11. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease.
Wang XZ; Xu K; Li Y; Jing QM; Liu HW; Zhao X; Wang G; Wang B; Ma YY; Chen SL; Han YL
Chin Med J (Engl); 2015 Mar; 128(6):721-6. PubMed ID: 25758262
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
14. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions.
Colombo F; Biondi-Zoccai G; Infantino V; Omedé P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Sheiban I
Acta Cardiol; 2009 Oct; 64(5):583-8. PubMed ID: 20058502
[TBL] [Abstract][Full Text] [Related]
15. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial.
Roguin A; Camenzind E; Kerner A; Beyar R; Boersma E; Mauri L; Steg PG; Wijns W
JACC Cardiovasc Interv; 2017 Mar; 10(6):548-556. PubMed ID: 28335893
[TBL] [Abstract][Full Text] [Related]
17. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
Zhang J; Gao X; Kan J; Ge Z; Han L; Lu S; Tian N; Lin S; Lu Q; Wu X; Li Q; Liu Z; Chen Y; Qian X; Wang J; Chai D; Chen C; Li X; Gogas BD; Pan T; Shan S; Ye F; Chen SL
J Am Coll Cardiol; 2018 Dec; 72(24):3126-3137. PubMed ID: 30261237
[TBL] [Abstract][Full Text] [Related]
18. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation.
Redfors B; Maehara A; Witzenbichler B; Weisz G; Stuckey TD; Henry TD; McAndrew T; Mehran R; Kirtane AJ; Stone GW; Généreux P
J Invasive Cardiol; 2017 Nov; 29(11):378-386. PubMed ID: 28623669
[TBL] [Abstract][Full Text] [Related]
19. Five-year outcomes in patients with chronic total coronary occlusion treated with drug-eluting vs bare-metal stents: a case-control study.
De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Scappaticci M; Confessore P; Guerra E; Belloni F; Violini R
Can J Cardiol; 2013 Aug; 29(8):945-50. PubMed ID: 23265094
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
Ohya M; Kadota K; Toyofuku M; Morimoto T; Higami H; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kimura T;
Am J Cardiol; 2017 Feb; 119(3):355-364. PubMed ID: 27887688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
